4//SEC Filing
Bucher James B 4
Accession 0001664928-25-000008
CIK 0001725160other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 6:40 PM ET
Size
5.7 KB
Accession
0001664928-25-000008
Insider Transaction Report
Form 4
Bucher James B
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-10-01+400,000→ 400,000 totalExercise: $1.54Exp: 2025-09-30→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The options will vest over a four-year period as follows: 25% of the options will vest on October 1, 2026, with the remaining 75% vesting in substantially equal monthly installments thereafter until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001664928
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 6:40 PM ET
- Size
- 5.7 KB